Χώρα: Ηνωμένες Πολιτείες
Γλώσσα: Αγγλικά
Πηγή: NLM (National Library of Medicine)
ABT-925 ANHYDROUS FREE BASE (UNII: E6CKI5C54O) (ABT-925 ANHYDROUS FREE BASE - UNII:E6CKI5C54O)
REMEDY MAKERS
SUBLINGUAL
PRESCRIPTION DRUG
unapproved homeopathic
MORPHINUM- MORPHINE PELLET REMEDY MAKERS _Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for_ _safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective._ ---------- CII WARNING "The FDA has not determined that the product is safe, effective and not misbranded for its intended use." INDICATION PAIN, NAUSEA, DIARRHEA, NEURITIS, OR OTHER INDICATIONS WARNING: Use only if cap and seal are unbroken. Keep this and all medications out of reach of children. If symptoms persist for more than 3 days or worsen, discontinue (STOP) use and consult your physician. As with any drug. If you are pregnant or nursing (breast-feeding) a baby, seek the advise of a health professional before using this product. Store tightly closed in a cool area. DIRECTIONS (ADULT/CHILDREN) Dissolve 3 or 4 pellets in mouth or under tongue 3 times a day or as directed by a physician. Children 2 years and older take 1/2 adult dose. INACTIVE INGREDIENTS Lactose and Sucrose. Free from yeast, wheat, corn and soy. OTHER INFORMATION Contains approx. 169 -172 pellets. QUESTIONS OR COMMENTS: (877) REM4YOU Fax (909) 594-4205 Pomona, CA. 91768 USA www.remedymakers.com CAUTION: Federal law prohibits dispensing wothout prescription. MORPHINUM REMEDY MAKERS morphine pellet PRODUCT INFORMATION PRODUCT T YPE HUMAN PRESCRIPTION DRUG ITE M CODE (SOURCE ) NDC:10 19 1-10 0 5 ROUTE OF ADMINISTRATION SUBLINGUAL DEA SCHE DULE CII ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH ABT-9 2 5 ANHYDRO US FREE BASE (UNII: E6 CKI5C54O) (ABT-9 25 ANHYDROUS FREE BASE - UNII:E6 CKI5C54O) ABT-9 25 ANHYDROUS FREE BASE 15 [hp_X] INACTIVE INGREDIENTS INGREDIENT NAME STRE NG TH SUCRO SE (UNII: C151H8 M554) PACKAG ING # ITEM CODE PACKAGE DESCRIPTION MARKETING START DATE MARKETING END DATE 1 NDC:10 19 1-10 0 5-2 16 9 in 1 VIAL, GLASS; Type 0 : No t a Co mbinatio n Pro duct 0 8 /0 6 /20 15 MARKETING INFORMATION MARKE TING CATE GORY APPLICATION NUMBE R OR MONOGRAPH CITATION MARKE Διαβάστε το πλήρες έγγραφο